
LeMaitre Vascular LMAT
$ 80.47
0.07%
Country |
|
IPO year |
2006 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
22.6 M |
Market Cap[1] |
$ 1.82 B |
EBITDA (LTM) |
$ 78.3 M |
P/E (LTM) |
31.635294 |
P/S (LTM) |
7.316478 |
EPS (LTM) |
2.55 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 67.55 | 2.29 % | $ 33.3 B | NYSE | ||
|
AngioDynamics
ANGO
|
$ 15.29 | 0.13 % | $ 635 M | Nasdaq Global Select Market | ||
|
AtriCure
ATRC
|
$ 55.7 | 2.12 % | $ 2.66 B | Nasdaq Global Market,SPB | ||
|
Baxter International
BAX
|
$ 23.71 | 0.02 % | $ 12.2 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 181.85 | 2.2 % | $ 52.3 B | NYSE,SPB | ||
|
BioLife Solutions
BLFS
|
$ 35.22 | 0.77 % | $ 1.68 B | Nasdaq Global Select Market | ||
|
The Cooper Companies
COO
|
$ 53.9 | 0.8 % | $ 10.7 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 9.66 | 0.42 % | $ 81.9 K | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 169.81 | 1.46 % | $ 9.71 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 105.54 | 2.85 % | $ 4.98 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 8.1 | 0.81 % | $ 360 M | Nasdaq Global Market | ||
|
ICU Medical
ICUI
|
$ 156.91 | 0.27 % | $ 3.87 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 12.22 | 0.74 % | $ 252 M | NYSE American | ||
|
iRhythm Technologies
IRTC
|
$ 113.9 | 2.21 % | $ 3.65 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 375.38 | 1.69 % | $ 134 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.15 | 0.32 % | $ 145 M | Nasdaq Capital Market | ||
|
Microbot Medical
MBOT
|
$ 1.46 | 0.68 % | $ 66.9 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.42 | 2.28 % | $ 34.5 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 86.77 | 0.47 % | $ 5.13 B | Nasdaq Global Select Market,SPB | ||
|
Nephros
NEPH
|
$ 4.39 | 0.22 % | $ 46.6 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 25.74 | 0.74 % | $ 4.32 B | NYSE | ||
|
Pro-Dex
PDEX
|
$ 66.05 | 5.16 % | $ 213 B | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.32 | 2.0 % | $ 244 M | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 54.79 | 3.16 % | $ 3.69 B | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 166.71 | 0.92 % | $ 9.37 M | Nasdaq Global Select Market,SPB | ||
|
ResMed
RMD
|
$ 222.73 | 2.09 % | $ 32.4 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.68 | 0.21 % | $ 20.4 M | NYSE American | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 22.92 | 1.15 % | $ 1.14 B | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 212.65 | 0.88 % | $ 20.9 B | NYSE,SPB | ||
|
Stereotaxis
STXS
|
$ 1.34 | 3.49 % | $ 122 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 130.42 | 0.34 % | $ 5.82 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 70.86 | 1.65 % | $ 230 M | Nasdaq Global Select Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
West Pharmaceutical Services
WST
|
$ 355.31 | 2.85 % | $ 25.7 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.37 | 0.62 % | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.